Neo-Adjuvant FOLFOX for Rectal Carcinoma

NCT00832299 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped terminated for lack of enrollment

Conditions

Rectal Neoplasms

Interventions

DRUG: FOLFOX
PROCEDURE: total mesorectal excision (TME)

Sponsor

Beth Israel Medical Center

Collaborators

[object Object]